Latest updates
- In the press Exonate’s CEO, Dr Catherine Beech, to present at BioTrinity 2018
- In the press Watch Exonate’s Chairman Sunil Shah and Angel Co Fund Investor Peter Cowley, feature in the British Business Bank Finance Guide video
- In the press Exonate’s CEO, Dr Catherine Beech to speak at The Commonwealth Innovation Forum (TCIF), Brisbane 2018
- In the press Watch Exonate’s principal scientist, Dr Jennifer Batson interviewed for Bermuda TV
- In the press Exonate’s principal scientist, Dr Jennifer Batson, to present at The Bermuda Principles Impact on Splicing 2nd Annual conference 2018 (BPIS)
- In the press Exonate’s principal scientist, Dr Jennifer Batson, to present at Pharmacology 2017
- In the press Wellcome – 10 ideas we fund that might surprise you. From eyeball injections to eye drops for sight loss
- In the press Exonate announces the formation of ophthalmology Clinical Advisory Board (“Exonate” or the “Company”)
- In the press Exonate is the ‘One to Watch’ in the Best Investment in Life Sciences
- In the press Exonate receives Wellcome Trust funding to develop eye drop treatment for wet age-related macular degeneration (wet AMD)